Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia
Reham Ahmed,Andrew L Feldman,Andrew L. Feldman
DOI: https://doi.org/10.1182/blood.2023022971
IF: 20.3
2024-03-08
Blood
Abstract:A 58-year-old man with a history of chronic lymphocytic leukemia (CLL) presented with 2 months of abdominal pain and night sweats. Imaging showed hypermetabolic abdominal, cervical, and axillary lymphadenopathy. Excisional biopsy of a 2.7-cm right axillary lymph node showed effacement of the lymph node architecture by a diffuse infiltrate of small lymphocytes with scattered proliferation centers (panel A, hemotoxylin and eosin [H&E] stain, 4× lens objective; panel B, H&E stain 40× lens objective). The sinusoids contained large atypical cells, including "hallmark" cells (panel C, H&E stain, 40× lens objective; inset, 100× lens objective). By immunohistochemistry, the small cells were positive for CD20 (weak; panel D, 40× lens objective), PAX5, CD5 (panel E, 40× lens objective), CD23 (panel F, 40× lens objective), and LEF1 (panel G, 40× lens objective) and negative for cyclin D1 (panel G, 40× lens objective; inset). The large cells were positive for CD30 (panel H, 4× lens objective; panel I, 40× lens objective) and weakly positive for CD2 and CD4 (panel J, 40× lens objective). Ki67 showed a high proliferation rate (panel K, 40× lens objective). They were negative for CD20, CD79a, PAX5, CD138, CD3, CD5, CD8, TIA1, granzyme B, and ALK (panel K, 40× lens objective; inset). Epstein-Barr virus encoded RNA was negative. Fluorescence in situ hybridization for DUSP22 and TP63 rearrangements was negative. These features indicated a composite lymphoma comprising CLL and ALK-negative anaplastic large cell lymphoma (ALCL).
hematology